Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
With a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this webinar, part of our Infectious Disease Webinar Series, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection.
Publish Date:
August 18, 2020
Related Multimedia
-
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation
Publish Date: April 20, 2016 -
STEMCELL Journal Club: Cerebral Organoids for Human-Specific Infection Modeling
Publish Date: May 25, 2020
Explore Our Products
-
cGMP, enzyme-free human pluripotent stem cell selection and passaging reagent -
Anti-SARS-CoV Nucleoprotein Antibody, Clone 001 (Recombinant)
Rabbit monoclonal IgG antibody against SARS-CoV, SARS-CoV-2 (2019-nCoV) Nucleoprotein (HEK293-expressed recombinant) -
STEMdiff™ Cerebral Organoid Kit
Culture medium kit for establishment and maturation of human cerebral organoids -
STEMdiff™ Neural Progenitor Medium
Medium for maintenance and expansion of neural progenitor cells derived from human ES and iPS cells
